Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) – 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS-3043 Category:

OVERVIEW

Amid the coronavirus outbreak, the global market for respiratory diagnostics is expected to grow from 2021 to 2026 at a CAGR of 6.3%. The major factors driving the growth of the global market are rising prevalence of respiratory diseases, growing geriatric population and technological advances in respiratory diagnostic systems. The study predicts the short term and long term trends that can shape the future of the market including the COVID-19 pandemic implications for the industry.

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 1

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 2

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 3

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 4

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 5

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 6

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 7

Respiratory Diagnostics Market by Disease (TB, Lung Cancer, COPD), Product & Service (Kits/Reagents, Instruments/Devices), Test Type (Imaging Test, Pulmonary Function Test), End User (Reference Laboratories, Physician Offices) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Respiratory Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Respiratory Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Respiratory Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Respiratory Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Respiratory Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Respiratory Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Respiratory Diagnostics Market – By Product and Service (Market Size – &
million/billion)
8.1 Instruments and Devices
8.2 Assays and Reagents
8.3 Services and Software

9 Global Respiratory Diagnostics Market – By Test Type
9.1 Traditional Diagnostic Tests
9.2 Imaging Tests
9.3 Mechanical Tests
9.4 Molecular Diagnostic Tests

10 Global Respiratory Diagnostics Market – By Disease
10.1 Chronic Obstructive Pulmonary Disease
10.2 Tuberculosis
10.3 Lung Cancer
10.4 Asthma
10.5 Other

11 Global Respiratory Diagnostics Market – By End-User
11.1 Hospital/Clinical Laboratories
11.2 Physician Offices
11.3 Reference Laboratories
11.4 Other

12 Global Respiratory Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Respiratory Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Respiratory Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Philips Healthcare
14.3 Thermo Fisher Scientific Inc.
14.4 Becton, Dickinson & Company
14.5 Abbott Laboratories
14.6 Cosmed
14.7 Seegene Inc.
14.8 Sdi Diagnostics
14.9 Biomérieux
14.10 Alere Inc.
14.11 Bio-Rad Laboratories, Inc.
14.12 Company 11 & more

15 Global Respiratory Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations